News

American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain's GSK and Germany's CureVac US$740 million plus royalties to ...
How Needle-Free Injections Enhance Patient Comfort, Boost Pharmaceutical Outcomes, and Eliminate Traditional Injection ...
BioNTech has agreed to pay UK drugmaker GSK royalties on its Covid-19 and influenza vaccines as part of a patent settlement with CureVac, in a deal that allows the biotech to move forward with the ...
Robert F. Kennedy Jr., the HHS Secretary of the US, despite a long history of the contray, now often pretends to be not against vaccinations. Yet, his recent actions depict an entirely different ...
The Trump administration says it is pulling half a billion dollars from U.S. government-funded research projects to create ...
The US Department of Health and Human Services (HHS) has terminated 22 messenger RNA vaccine research projects, totalling ...